Sunday, January 28, 2018 12:24:16 AM
1) assuming that none of the remaining .023 warrants have been exercised between then and now which I think is a stretch to assume since almost 40 million of the .023 warrants had already been exercised as of 09/30/17 and the price is substantially higher now than it was then, then there are just under 100 million warrants remaining .023. Note that this deal was made as a part of CBW buying the company who had secured some of the early streaming deals and coming public. It's a cost of doing business, and in the scheme of things, 100 million shares isn't that many, especially because as I said previously, I highly doubt that there are even 100 million left at this point.
2) There are 12,716,085 employee stock options exercisable at .025 outstanding (again assuming that none have been exercised between now and then
3) There are 15 million warrants from June 2017 exercisable at $1.50
4) There are 24 million warrants from June 2017 exercisable at $1.00
In total, again assuming that NO additional warrant or option exercises have occurred between 09/30/17 and now, at most there could be about 150 million warrants/options outstanding with proceeds to the company of $47 million in proceeds to the CBW. Not ideal, but certainly not the end of the world, because my guess is that at least an addt'l 40 million of the .023 warrants have been exercised already, just assuming that the same amount were exercised in the 4th quarter of 2017 as were exercised in the 3rd quarter. I'll have to try to dig up a more recent filing to see if there are any updated numbers, but regardless, the estimates I did were based on a billion total shares outstanding, so even with these addt'l shares, they'll still likely fall well below that total # of shares when it's all said and done...that being said, if you notice anything I overlooked (because admittedly I stopped at the charts that showed what warrants/options were still outstanding, please let me know because my goal is to understand exactly where they stand. I would say I am pretty sure that all of these options and warrants would already be included in their full-diluted share count as well.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM